Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
superoxide dismutase/põletik
Link salvestatakse lõikelauale
Leht 1 alates 28 tulemused
Modified superoxide dismutase
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates generally to the field of administration of superoxide dismutase (SOD) to reduce ischemic injury or injury following sepsis or inflammation. In particular, this invention relates to a method and compositions for reducing toxic side effects
Gene sequence of Aquifex pyrophilus superoxide dismutase and protein expressed in Escherichia coli
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a gene sequence of superoxide dismutase of Aquifex pyrophilus and protein expressed in Escherichia coli.
2. Description of the Prior Art
Recently, there has been a variety of attempts to isolate enzymes from the
Superoxide dismutase derivatives, method of producing same and medicinal use of same
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. FIELD OF THE INVENTION
This invention relates to superoxide dismutase derivatives, a method of producing the same and medicinal use of the same.
2. DESCRIPTION OF THE PRIOR ARTS
Superoxide dismutase (hereinafter abbreviated as SOD) has been known so far as an enzyme
Metal abstraction peptide with superoxide dismutase activity
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy, created on Aug. 8, 2013, is named 41861-702.201_SL.txt and is 3,120 bytes in size.
BACKGROUND OF THE INVENTION
Peptide
Use of GHL-Cu as a wound-healing and anti-inflammatory agent
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to the treatment of wounds in animals in general, and more specifically, to the use of a peptide having human superoxide dismutase activity, glycyl-L-hystidyl-L-lysine: copper(II), for enhancing the wound-healing process.
BACKGROUND ART
Mechanisms of
Method for alleviating skin irritation by formulations containing superoxide dismutase
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
Adverse skin reactions caused by chemical irritants are common among humans. Many of these irritants are constituents of cosmetic products while others are noxious industrial chemicals including organic solvents and caustic materials. In view of this wide spectrum of
Composition for preventing or alleviating skin irritation by formulations containing superoxide dismutase
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
Adverse skin reactions caused by chemical irritants common among humans. Many of these irritants are constituents of cosmetic products while others are noxious industrial chemicals including organic solvents and caustic materials. In view of this wide spectrum of
Biomaterials modified with superoxide dismutase mimics
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to biomaterials modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. This modification may be by covalent conjugation, copolymerization, or admixture of the non-proteinaceous
Manganese superoxide dismutase regulatory elements and uses thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The invention relates to novel transcriptional regulatory elements derived from manganese superoxide dismutase (MnSOD) genes, as well as methods of identifying and using the regulatory elements to control gene expression.
BACKGROUND OF THE INVENTION
Precise control of
Superoxide dismutase-4
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is Superoxide
Superoxide dismutase-4
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is Superoxide
Antibodies to superoxide dismutase-4
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is Superoxide
Composition for protecting skin from damaging effects of ultraviolet light
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention concerns a topical antioxidant composition for the protection and treatment of human skin, particularly skin that is exposed to harmful ultraviolet radiation.
BACKGROUND OF THE INVENTION
The ultraviolet (UV) wavelengths of sunlight can cause sunburn (erythema)
Composition for protecting skin from damaging effects of ultraviolet light
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention concerns a topical antioxidant composition for the protection and treatment of human skin, particularly skin that is exposed to harmful ultraviolet radiation.
BACKGROUND OF THE INVENTION
The ultraviolet (UV) wavelengths of sunlight can cause sunburn (erythema)
Methods for protecting skin from damaging effects of ultraviolet light
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention concerns a topical antioxidant composition for the protection and treatment of human skin, particularly skin that is exposed to harmful ultraviolet radiation.
BACKGROUND OF THE INVENTION
The ultraviolet (UV) wavelengths of sunlight can cause sunburn (erythema)
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
